ASX - By Stock
|
IMU |
Re:
Check-vacc - possible complete response case study!
|
|
Tifosi
|
78 |
34K |
15 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
78
|
34K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Check-vacc - possible complete response case study!
|
|
Tifosi
|
78 |
34K |
91 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
78
|
34K
|
91
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Tifosi
|
22K |
11M |
12 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
22K
|
11M
|
12
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata announces CEO succession and Board changes
|
|
Tifosi
|
84 |
25K |
9 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
84
|
25K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata completes $5.0m Placement and launches SPP
|
|
Tifosi
|
22 |
6.6K |
4 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
22
|
6.6K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Trading Halt
|
|
Tifosi
|
72 |
17K |
2 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
72
|
17K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Trading Halt
|
|
Tifosi
|
72 |
17K |
3 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
72
|
17K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FIRST COHORT 3 PATIENT DOSED IN CLINICAL TRIAL OF CHECKVACC
|
|
Tifosi
|
77 |
47K |
31 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
77
|
47K
|
31
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results
|
|
Tifosi
|
439 |
227K |
16 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
439
|
227K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Novartis walked due to "sub par data".
|
|
Tifosi
|
143 |
41K |
2 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
143
|
41K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Tifosi
|
22K |
11M |
0 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
22K
|
11M
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Called it ! A must read
|
|
Tifosi
|
222 |
129K |
11 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
222
|
129K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: PD1-Vaxx Presentation at ESMO Congress 2021 Annual Meeting
|
|
Tifosi
|
108 |
59K |
2 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
108
|
59K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Trading Halt
|
|
Tifosi
|
414 |
200K |
17 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
414
|
200K
|
17
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Tifosi
|
22K |
11M |
24 |
22/05/21 |
22/05/21 |
ASX - By Stock
|
22K
|
11M
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Tifosi
|
13K |
6.2M |
25 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
13K
|
6.2M
|
25
|
|
ASX - By Stock
|
IMU |
Re:
KEEP IMU AUSTRALIAN OWNED
|
|
Tifosi
|
135 |
66K |
2 |
17/05/21 |
17/05/21 |
ASX - By Stock
|
135
|
66K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
KEEP IMU AUSTRALIAN OWNED
|
|
Tifosi
|
135 |
66K |
19 |
16/05/21 |
16/05/21 |
ASX - By Stock
|
135
|
66K
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Rubbing my ball
|
|
Tifosi
|
1.6K |
921K |
35 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
1.6K
|
921K
|
35
|
|
ASX - By Stock
|
IMU |
Re:
B-vaxx - a sleeper surprise?
|
|
Tifosi
|
78 |
46K |
9 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
78
|
46K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
B-vaxx - a sleeper surprise?
|
|
Tifosi
|
78 |
46K |
2 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
78
|
46K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
B-vaxx - a sleeper surprise?
|
|
Tifosi
|
78 |
46K |
5 |
18/04/21 |
18/04/21 |
ASX - By Stock
|
78
|
46K
|
5
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Tifosi
|
31K |
15M |
14 |
16/04/21 |
16/04/21 |
Charts
|
31K
|
15M
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Tifosi
|
22K |
11M |
13 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
22K
|
11M
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Tifosi
|
13K |
6.2M |
0 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
13K
|
6.2M
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Friday thoughts IMU
|
|
Tifosi
|
217 |
96K |
6 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
217
|
96K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
The Importance of P values to clinical trials
|
|
Tifosi
|
14 |
7.7K |
9 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
14
|
7.7K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Re:Re:Charts:Imugene
|
|
Tifosi
|
1.3K |
648K |
1 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
1.3K
|
648K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Re:Re:Charts:Imugene
|
|
Tifosi
|
1.3K |
648K |
4 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
1.3K
|
648K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
IPO - Chimeric Therapeutics Limited - 18 January 2021 #
|
|
Tifosi
|
303 |
159K |
3 |
08/01/21 |
08/01/21 |
ASX - By Stock
|
303
|
159K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Whats Next
|
|
Tifosi
|
57 |
42K |
11 |
04/01/21 |
04/01/21 |
ASX - By Stock
|
57
|
42K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Enrols First Cohort of PD1-Vaxx Clinical Trial
|
|
Tifosi
|
71 |
39K |
10 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
71
|
39K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
Tifosi
|
796 |
393K |
3 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
796
|
393K
|
3
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Imugene - Charts & Price Action (New thread)
|
|
Tifosi
|
1.7K |
912K |
7 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
1.7K
|
912K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
CF33 activates immune system against Colon Cancer
|
|
Tifosi
|
18 |
13K |
6 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
18
|
13K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Tifosi
|
13K |
6.2M |
54 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
13K
|
6.2M
|
54
|
|
ASX - By Stock
|
CYP |
Re:
Questions for the Board at the AGM 2020
|
|
Tifosi
|
88 |
17K |
2 |
28/11/20 |
28/11/20 |
ASX - By Stock
|
88
|
17K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Imugene's Leslie Chong says positive HER-Vaxx data 'validates entire platform'
|
|
Tifosi
|
282 |
115K |
6 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
282
|
115K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Imugene's Leslie Chong says positive HER-Vaxx data 'validates entire platform'
|
|
Tifosi
|
282 |
115K |
4 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
282
|
115K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
AGM live chat
|
|
Tifosi
|
82 |
30K |
3 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
82
|
30K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene HER Vaxx shows positive Overall Survival in trial
|
|
Tifosi
|
254 |
110K |
3 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
254
|
110K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene HER Vaxx shows positive Overall Survival in trial
|
|
Tifosi
|
254 |
110K |
30 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
254
|
110K
|
30
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene HER Vaxx shows positive Overall Survival in trial
|
|
Tifosi
|
254 |
110K |
6 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
254
|
110K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene HER Vaxx shows positive Overall Survival in trial
|
|
Tifosi
|
254 |
110K |
20 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
254
|
110K
|
20
|
|
ASX - By Stock
|
IMU |
Re:
Bed & Breakfast No Brainer
|
|
Tifosi
|
120 |
53K |
0 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
120
|
53K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Mesoblast and Novartis collaboration
|
|
Tifosi
|
148 |
23K |
7 |
22/11/20 |
22/11/20 |
ASX - By Stock
|
148
|
23K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
TYPE A OUTCOME AND NOVARTIS PARTNERSHIP
|
|
Tifosi
|
111 |
55K |
10 |
22/11/20 |
22/11/20 |
ASX - By Stock
|
111
|
55K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
Tifosi
|
811 |
332K |
5 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
811
|
332K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Mesoblast and Novartis collaboration
|
|
Tifosi
|
148 |
23K |
6 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
148
|
23K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Bed & Breakfast No Brainer
|
|
Tifosi
|
120 |
53K |
18 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
120
|
53K
|
18
|
|